A shadow market for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.
Experimental Treatment Gaining Popularity Online
The experimental drug, which remains in research studies, is being promoted by social media influencers for its alleged weight-reducing effects. Viewers are encouraged to message these profiles directly for supplier links, while also receiving promotional offers.
Thriving Commerce on Social Networks
Separately, a robust market exists on messaging services, where communities with numerous of members share “before and after” photos, administration instructions and claims of next-day UK delivery. Vendors market the drug there before redirecting buyers to other platforms for transactions.
Understanding Retatrutide
This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could assist patients lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.
Healthcare Experts Voice Concerns
However, doctors and pharmacists have warned that the distribution of what is still an unapproved medication in the UK is worrisome and could lead to individuals injecting products of uncertain source.
Some professionals said the popularity for the experimental drug could be connected to the increasing price of licensed weight loss products such as Mounjaro.
Regulatory Position and Enforcement
Selling the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unapproved drug that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.
Several influencers attempt to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still breach medicines, advertising, and customer regulations, potentially leading to penalties, legal action or imprisonment.
Service Response and Material Elimination
Based on the social media company, the service has taken down violative material and prohibited related hashtags and search suggestions. The company said it was committed to keeping the service secure and investing in enhancing compliance measures.
Online Marketplace Activities
Investigations also discovered groups with up to 9,000 participants selling retatrutide using the platform's integrated search feature, which functions like a public directory. Entering “retatrutide” immediately displays groups with numerous of members, populated with images of slimming results, positive testimonials and detailed instructions for preparing or injecting at residence.
Within minutes of entering one group, a vendor posted WhatsApp details, where the majority of transactions occur. The seller provided an instruction manual and promised delivery within two days. When questioned whether the product was genuine, one seller said: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one asked about weight, medical conditions or past usage.
Item Details and Costs
Inside these groups, messages display black plastic parcels with postal service stickers, stating to include new batches. One message stated: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, prepared at home with purified liquid, or pre-filled injectors usually priced at £160 for 20 milligrams. When asked how much time a injector should be used, sellers give contradictory responses ranging from a few weeks to “depends on your body”.
Service Oversight and Security Actions
A spokesperson for the messaging service stated it actively monitored harmful content on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Medical Professional Warnings
“Individuals are injecting substances they cannot confirm. Even if the research behind retatrutide is valid, these digital versions may not contain what they claim,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to current price rises for approved weight-loss medications such as Mounjaro. “With prices increasing, patients are using social media. But fake injections are extremely risky. You cannot know what’s contained or whether the conditions they were made in was clean,” she said.
Her staff has already seen patients harmed by self-injection from unverified suppliers. “We understand the disappointment, but purchasing from Telegram or communication platforms is gambling with your health,” stated the doctor. “These materials could be contaminated or improperly measured.”
Manufacturer Statement
A spokesperson from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Consequently at this point no one can market [it] for human use,” they explained, noting that any product “falsely representing itself as a company experimental substance not yet approved … may subject users to possibly significant medical dangers”.
